Outcome is worse in male compared to female de novo aml patients and can be improved with the use of granulocyte colony stimulating factor(g-csf) during induction.: Results of a randomized multicentric trial(Turkish leukemia study group (tlg95-002).

Beksaç, MÖzcan, MDündar, SBayık, MPaydaş, S. ABüyükaşık, Yİlhan, OGürman, GUysal, AAkan, HAkcağlayan, EÖzdemir, O2024-09-032024-09-032002-11-160006-4971https://hdl.handle.net/11452/44276Bu çalışma, 06-10 Aralık 2002 tarihleri arasında Philadelphia[ABD]’da düzenlenen 44. Annual Meeting of the American-Society-of-Hematology’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineHematologyOutcome is worse in male compared to female de novo aml patients and can be improved with the use of granulocyte colony stimulating factor(g-csf) during induction.: Results of a randomized multicentric trial(Turkish leukemia study group (tlg95-002).Meeting Abstract000179184801070251B251B10011, Part 2